Crystal structures of Saccharomyces cerevisiae tryptophanyl-tRNA synthetase: new insights into the mechanism of tryptophan activation and implications for anti-fungal drug design by Zhou, Minyun et al.
Crystal structures of Saccharomyces cerevisiae
tryptophanyl-tRNA synthetase: new insights into
the mechanism of tryptophan activation and





1,* and Jianping Ding
1,*
1State Key Laboratory of Molecular Biology and Research Center for Structural Biology, Institute of
Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and
2Graduate School of Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, China
Received November 25, 2009; Revised December 29, 2009; Accepted December 30, 2009
ABSTRACT
Specific activation of amino acids by aminoacyl-
tRNA synthetases is essential for maintaining
translational fidelity. Here, we present crystal struc-
tures of Saccharomyces cerevisiae tryptophanyl-
tRNA synthetase (sTrpRS) in apo form and in
complexes with various ligands. In each complex,
there is a sulfate ion bound at the active site which
mimics the a-o rb-phosphate group of ATP during
tryptophan activation. In particular, in one monomer
of the sTrpRS–TrpNH2O complex, the sulfate ion
appears to capture a snapshot of the a-phosphate
of ATP during its movement towards tryptophan.
Simulation study of a human TrpRS–Trp–ATP
model shows that during the catalytic process the
a-phosphate of ATP is driven to an intermediate
position equivalent to that of the sulfate ion, then
moves further and eventually fluctuates at around
2A ˚ from the nucleophile. A conserved Arg may
interact with the oxygen in the scissile bond at
the transition state, indicating its critical role
in the nucleophilic substitution. Taken together,
eukaryotic TrpRSs may adopt an associative mech-
anism for tryptophan activation in contrast to a
dissociative mechanism proposed for bacterial
TrpRSs. In addition, structural analysis of the apo
sTrpRS reveals a unique feature of fungal TrpRSs,
which could be exploited in rational antifungal drug
design.
INTRODUCTION
Aminoacyl-tRNA synthetases (aaRSs) are an ancient
family of enzymes that play a central role in protein syn-
thesis. They speciﬁcally catalyze the transfer of amino
acids to their cognate tRNAs, which is critical for main-
taining the ﬁdelity of the translation process. Basically, the
aminoacylation reaction proceeds in two steps including
the phosphoryl transfer from ATP to the amino acid to
generate an aminoacyl-AMP intermediate (the amino acid
activation step) and the subsequent attachment of the
aminoacyl moiety of the activated amino acid to the
acceptor stem of the cognate tRNA (the acyl-transfer
step) (1). According to the sequence homology and
structural similarity, aaRSs can be divided into two
classes (2–5). Class I aaRSs have two highly conserved
motifs (HIGH and KMSKS) at the catalytic domain
which contains a Rossmann fold (RF) composed of
parallel b-strands and a-helices; Class II aaRSs are
characterized by three conserved sequence motifs and
the catalytic domain exhibits a unique fold of anti-parallel
b-strands ﬂanked by a-helices. Each class can be further
grouped into three subclasses with the synthetases within
the same subclass sharing common sequence and
structural features (6,7). Tryptophanyl-tRNA synthetase
(TrpRS) belongs to subclass Ic, containing an additional
GXDQ motif besides the HIGH and KMSKS motifs.
Due to the importance of the phosphoryl transfer
reaction in a vast variety of biological processes, the
mechanisms underlying nucleophilic substitution at
phosphoryl groups have received much attention (8,9).
For these reactions, two mechanisms (dissociative and
associative) have been proposed: in a reaction proceeding
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attack the bond to the leaving group is already
weakened or broken, leading to formation of a hydrated
PO3O
  anion; while in that with an associative mecha-
nism, the nucleophile approaches Pa before the bond
breaks and a pentavalent phosphorus forms at the transi-
tion state (10). However, the diﬀerences between the asso-
ciative and dissociative mechanisms are subtle with the
energetics of the two mechanisms in solution being com-
parable, suggesting that phosphoryl transfer reactions
could proceed with either mechanism (10).
Recently, structural and computational studies
of TrpRSs from Baccillus stearothermophilus (bTrpRS)
(11–19) and Homo sapiens (hTrpRS) (20–26) have been
performed to investigate how the enzymes catalyze the
phosphoryl transfer during the Trp activation step.
Comparison of the eukaryotic TrpRS with the bacterial
TrpRS demonstrates marked diﬀerences in various
aspects. Speciﬁcally, structural comparison of the
bTrpRS–TrpNH2O–ATP complex (representing the
pre-transition state) and the bTrpRS–TrpAMP complex
(representing the product state) revealed an average
movement of the Ca atoms of the KMSKS loop by
1.3A ˚ , indicating that the phosphoryl transfer in Trp acti-
vation occurs with a rearrangement of the KMSKS loop
(13,14), which is supported by further simulation study of
the bTrpRS–Trp–ATP–Mg
2+ complex (15). In contrast,
analysis of the corresponding hTrpRS structures shows a
similar conﬁguration of the equivalent KMSAS loop
without signiﬁcant positional displacement (26).
Recently, Retailleau et al. proposed that bTrpRS might
utilize a dissociative mechanism in the Trp activation step
(16–18) mainly based on the structure of bTrpRS in
complex with an ATP analog, adenosine-50 tetraphosphate
(AQP) and a transition-state model derived from this
structure (17). In particular, at the active site, two lysine
residues (Lys111 in an insertion and Lys195 of the
KMSKS loop) are suggested to play important roles in
the Trp activation reaction, which is conﬁrmed by the
recent mutational studies by Weinreb et al. (19).
However, in eukaryotic TrpRSs, Lys111 is missing and
Lys195 is replaced by an Ala which obviously is incapable
of exerting similar functions as Lys195 of bTrpRS. Taken
together, the diﬀerences in the conﬁgurations of the key
KMSAS motif observed in the binary complexes and the
absence of the critical Lys residues suggest that the
tryptophan activation reaction of eukaryotic TrpRS
might proceed with an alternative mechanism from that
of bacterial TrpRS.
Here, we report the crystal structures of Saccharomyces
cerevisiae TrpRS (sTrpRS) in the apo form and in
complexes with Trp, TrpNH2O (a Trp analog), and
TrpAMP, respectively. Intriguingly, in each complex a
sulfate ion is bound at the active site, and in particular,
in one monomer of the sTrpRS–TrpNH2O complex, the
sulfate ion occupies a unique position and appears
to mimic an intermediate state of the a-phosphate of
ATP during the nucleophilic substitution reaction.
We also present the results of simulation studies of
the hTrpRS–TrpNH2O–ATP structure and the modeled
hTrpRS–Trp–ATP and hTrpRS–ATP complexes.
Our structural and computational studies not only reveal
the key structural elements and residues of sTrpRS
involved in the recognition and binding of the ligands,
but also provide new insights into the catalytic mechanism
of Trp activation by eukaryotic TrpRSs. Additionally,
by detailed comparison of the structure of the apo
sTrpRS with that of hTrpRS, we identify a potential
drug-targeting site of fungal TrpRSs.
MATERIALS ANS METHODS
Cloning, expression and puriﬁcation of sTrpRS
The yeast trpS gene fragment was ampliﬁed by PCR using
genomic DNA of S. cerevisiae as the template and
subsequently inserted into the NcoI and XhoI restriction
sites of the pET3E expression vector (Novagen) which
adds a hexahistidine tag to the C-terminus of the protein
product. The plasmid was transformed to the Escherichia
coli strain BL21 (DE3) and when the transformed cells
reached an OD600 of 0.6–0.8, 1mM IPTG was added to
induce the expression of sTrpRS. After 4 more hours’
culture at 37 C, the E. coli cells were harvested
and lysed by sonication in the lysis buﬀer (50mM
NaH2PO4/Na2HPO4, pH 8.0, 300mM NaCl, 5mM
2-mercaptoethanol and 1mM PMSF).
Puriﬁcation of the sTrpRS protein was carried out with
Nickel aﬃnity chromatography using an Ni-NTA agarose
column (Qiagen) following the standard protocol. The
supernatant fraction of the lysate was applied onto an
Ni-aﬃnity column pre-equilibrated with the lysis buﬀer,
and the column was loaded with the washing and elution
buﬀers (the lysis buﬀer supplemented with 20mM and
200mM imidazole, respectively) in turn. The elution frac-
tions containing the puriﬁed sTrpRS protein were pooled,
followed by dialyzation against the storage buﬀer (20mM
Tris–HCl, pH 8.0, 2mM MgCl2, 5mM 2-mercaptoethanol
and 1mM PMSF). The protein solution was then
concentrated to 15mg/ml for crystallization experiments.
Crystallization and diﬀraction data collection
Screening of crystallization conditions was carried out at
20 C using the hanging drop vapor diﬀusion method. The
drops were prepared by mixing equal volumes (2ml each)
of the protein solution and the crystallization solution.
Crystals of the apo sTrpRS were obtained from drops
with the crystallization solution containing 0.1M MES
buﬀer, pH 6.5, 0.05M CsCl and 30% v/v Jeﬀamine
M-600 Reagent. The crystals grew to maximum dimen-
sions of 0.2 0.2 0.2 mm
3 within 2 days. Crystals of
sTrpRS in complexes with Trp or Trp analog TrpNH2O
were obtained from drops with the crystallization solution
[0.1M HEPES, pH 5.9, and 2.2M (NH4)2SO4] supple-
mented with 0.5ml of 20mM Trp or TrpNH2O. Both
types of crystals grew to maximum dimensions of
0.3 0.3 0.2 mm
3 within a week. Crystals of sTrpRS
in complex with TrpAMP were obtained by adding
0.5ml of 100mM ATP to a drop containing the
pregrown crystals of the sTrpRS–Trp complex, as it has
been shown by the previous study that in the presence of
Trp and ATP, the Trp activation reaction took place in
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mation of TrpAMP (26). Data collection was performed
at about 48h later to allow the completeness of the
reaction. The X-ray diﬀraction data of the apo sTrpRS
and the sTrpRS complexes were collected from
ﬂash-cooled crystals at beamlines BL6A and NW12 of
Photon Factory, Japan, respectively. The diﬀraction
data were processed using the HKL2000 program
package (27), and the crystal parameters and the
data-processing statistics are summarized in Table 1.
In an attempt to obtain the structure of sTrpRS in
complex with TrpNH2O and ATP, crystallization trials
were set out by co-crystallization of the enzyme with
TrpNH2O and ATP. Crystals grew in drops containing
2ml each of the protein solution and the crystallization
solution [0.1M HEPES, pH 5.9 and 2.2M (NH4)2SO4]
supplemented with 0.5ml of 20mM TrpNH2O and
100mM ATP. However, structure determination indicated
that no ATP is bound at the active site of the structure,
while TrpNH2O and a sulfate ion are bound at the active
site in the same way as in the TrpNH2O binary complex.
The binding of the sulfate ion instead of ATP is mostly
likely due to the presence of ammonium sulfate as the
precipitant.
Structure determination and reﬁnement
The structure of the apo sTrpRS was solved by the
molecular replacement method implemented in the
program CNS (28) using the structure of the apo
hTrpRS (PDB code 1O5T) (22) as the search model. The
structures of the sTrpRS–Trp, sTrpRS–TrpNH2O and
sTrpRS–TrpAMP complexes were determined by
the molecular replacement method implemented in the
program PHASER (29) of the CCP4 suite (30) using the
structure of the apo sTrpRS as the starting model. Initial
structure reﬁnement was carried out with the program
CNS following the standard protocol and ﬁnal structure
reﬁnement was performed using the maximum likelihood
algorithm implemented in the program REFMAC5 (31).
Model building was performed manually with the
programs COOT (32) and O (33). For the sTrpRS
complexes, there are two homodimers in an asymmetric
unit and the two dimers were reﬁned independently.
Throughout the reﬁnement, 5% of randomly chosen
reﬂections were set aside for free R factor monitor, a
bulk solvent correction was applied and PROCHECK
(34) was used to check the stereochemical quality of
these structural models. A summary of the statistics of
the structure reﬁnement is listed in Table 1.
Molecular modeling and dynamics simulation
Due to the impossibility of obtaining a crystal structure of
the transition-state complex, computational studies of the
catalytic process were carried out with construction of
an hTrpRS–Trp–ATP model and subsequent molec-
ular dynamics (MD) simulations of the complex.
Table 1. X-ray diﬀraction data and structure reﬁnement statistics
E E-Trp E-TrpNH2O E-TrpAMP
Statistics of diﬀraction data
Space group P43212 P61 P61 P61
Cell parameters
a=b (A ˚ ) 55.9 252.6 252.3 251.8
c (A ˚ ) 313.8 111.8 111.4 111.1
Resolution range (A ˚ ) 50.0–2.1 50.0–2.8 50.0–3.0 50.0–2.6
(2.18–2.10)
a (2.90–2.80) (3.11–3.00) (2.69–2.60)
No. of observed reﬂections 268709 665661 450584 532795
No. of unique reﬂections (I/s(I)> 0) 29469 99766 79287 118348
Average redundancy 9.1 (9.5) 6.7 (5.1) 5.7 (5.4) 4.5 (2.3)
I/s(I) 24.1 (4.0) 21.4 (3.3) 16.0 (2.3) 18.8 (3.2)
Completeness (%) 96.6 (98.5) 99.6 (98.7) 97.9 (95.1) 96.3 (83.4)
Rmerge (%)
b 10.2 (58.6) 8.6 (36.3) 11.7 (50.7) 5.6 (34.4)
Statistics of reﬁnement and model
No. of reﬂections (Fo 0s(Fo)) 29427 99520 79131 118158
Working set 27956 94506 75143 112240
Free Rset 1471 5014 3988 5918
Rfactor (%)
c 20.7 21.6 24.7 21.4
Free Rfactor (%) 23.8 24.7 27.3 23.7
No. of protein residues 373 1630 1628 1630
Average B factor of all atoms (A ˚ 2) 37.4 67.2 80.6 53.4
Protein main-chain atoms 36.2 66.6 80.7 53.0
Protein side-chain atoms 38.5 67.7 80.6 53.8
Ligand atoms – 59.9 74.0 33.8
RMS bond lengths (A ˚ ) 0.008 0.007 0.006 0.006
RMS bond angles ( ) 1.1 1.0 0.9 1.0
Ramachandran plot (%)
Most favored regions 95.7 93.5 93.0 93.9
Allowed regions 4.3 6.5 6.9 5.9
Generously allowed 0.0 0.0 0.1 0.1
aNumbers in parentheses refer to the highest resolution shell.
bRmerge=||I0|   <I>|/<I>.
cRfactor=||Fo|   |Fc||/|Fo.
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hTrpRS–TrpNH2O–ATP complex by replacement of
TrpNH2O with Trp. Due to the unavailability of an
Mg
2+-containing structure of eukaryotic TrpRS, an
Mg
2+ ion was docked to the complex based on the
bTrpRS–ATP–Mg
2+ structure (13) and simulations of
the hTrpRS–Trp–ATP complex were performed in the
presence or absence of the ion. It should be noted that,
in the eukaryotic TrpRS the metal ion may take a conﬁg-
uration diﬀerent from that of the docked Mg
2+ ion, as the
electrostatic microenvironment at the active site and the
conformational changes associated with the catalysis are
diﬀerent between the eukaryotic and bacterial TrpRSs.
For comparison, a model of the hTrpRS–ATP complex
was constructed by removal of the TrpNH2O molecule
from the hTrpRS–TrpNH2O–ATP structure, and simula-
tions of the hTrpRS–ATP model and the hTrpRS–
TrpNH2O–ATP complex were also performed. MD
simulations were carried out using the software package
Groningen Machine for Chemical Simulations
(GROMACS) 3.3 (35) with the GROMOS 53a6 force
ﬁeld (36). The topologies and parameters of Trp,
TrpNH2O and ATP were deﬁned by the PRODRG
server using the GROMOS 96.1 force ﬁeld (37). The
starting structures were ﬁrst subjected to energy minimi-
zation, and subsequently placed in the center of a box
which extended a minimum of 10A ˚ from the protein
surface and solvated with Simple Point Charge (SPC)
water molecules (38). In addition to the proteins and
ligands, the system contains about 14000 water molecules
and 7 or 8 Na
+ ions to neutralize the charges in the
system. A short equilibration run of 20ps was then per-
formed with the protein atoms being restrained and the
system gradually heated to 300K, followed by 5ns of the
production run with the temperature maintained at 300K
and the system pressure coupled using the Berendsen
method (39). The electrostatic interactions were evaluated
using the Particle-Mesh Ewald method (40,41) with a real
space cut-oﬀ of 1.0nm and the Van der Waals interactions
were modeled by a Lennard-Jones potential with a 1.4nm
cut-oﬀ. All of the bonds were constrained for the protein
using the LINCS algorithm (42). Simulations of each
set-up were repeated four times with diﬀerent random
initial velocities. The overall root mean square ﬂuctua-
tions of the proteins and the theoretical B factors were
calculated using the Ca atoms only.
RESULTS
Overall structures
The crystal structure of the apo sTrpRS was determined at
2.1A ˚ resolution (Table 1 and Figure 1A). In this structure,
the asymmetric unit contains one monomer, and two
monomers related by a 2-fold crystallographic symmetry
form a homodimer. This structure is almost identical to
that reported by Malkowski et al. (43) with a root mean
square deviation (RMSD) of 0.2A ˚ for all Ca atoms (here-
after our structure of the apo sTrpRS will be used for fur-
ther discussion). The structures of sTrpRS in complexes
with Trp, TrpNH2O and TrpAMP (Figure 1B) were
determined at a resolution of 2.8A ˚ , 3.0A ˚ and 2.6A ˚ ,
respectively. In all these complex structures, there are
two homodimers in one asymmetric unit which are
related by 2-fold noncrystallographic symmetry.
Respective superposition of the two dimers of the asym-
metric unit for each complex all yields an RMSD of
 0.3A ˚ for all Ca atoms, indicating that the two dimers
are quite similar.
Similar to hTrpRS, sTrpRS is composed of three
domains (Figure 1A and B): an N-terminal domain
(residues 1–99), an RF catalytic domain (residues
100–308 and 399–432) and a C-terminal a-helical
domain (residues 309–398). As shown in Figure 1A and
B, the catalytic active site of sTrpRS resides in a deep
pocket of the RF domain and contains a Trp-binding
subsite and an ATP-binding subsite. It is composed of
several conserved structural elements including the
N-terminal b-hairpin (residues 25–33), the KMSAS loop
(residues 289–303), the HLGH motif (residues 117–120,
helix g1), the AIDQ motif (residues 256–259, helix g5
and a15) and the linker region (residues 282–289) which
connects the KMSAS loop to the core of the RF domain
(the nomenclature of the secondary structure of sTrpRS is
after that of hTrpRS deﬁned by Yang et al. (25) for con-
sistency). In the apo structure, all the residues are evident
with good electron density except the N-terminal 44
residues (including the b-hairpin) and a region (residues
292–299) containing the conserved KMSAS loop. In the
binary complex structures, residues 21 to 398, including
the b-hairpin and the KMSAS loop are resolved, while the
N-terminal 20 residues are not observed. The invisibility
of the N-terminal part is probably due to the internal ﬂex-
ibility of this segment rather than degradation of the
region as the full-length protein was present in the
crystals according to the result of the SDS–PAGE
analysis (data not shown). In the complex structures, at
each active site the bound ligand (Trp, TrpNH2Oo r
TrpAMP) displays high quality electron density
(Supplementary Figure S1). Intriguingly, there is also a
sulfate ion bound at the active site of each monomer of
all three complexes (see the section ‘sulfate binding at the
active site’ later).
Comparisons of the apo structure with the complexed
structures show that the apo sTrpRS assumes an open
conformation with the N- and C-termini relatively far
from the RF domain (Figure 1C and Supplementary
Table S1). Upon ligand binding, sTrpRS transforms to a
compact conformation with the movement of the AIDQ
motif towards the active site, followed by the rotation of
the N- and C-terminal domains towards the RF domain
and the closure of the KMSAS loop taking either a closed
(in almost all the complexes) or a quasi-closed (in one
monomer of the sTrpRS–TrpNH2O complex, see
‘Discussion’ section later) conformation. The N-terminal
b-hairpin is also stabilized covering the active site
(Figure 1C and Supplementary Table S1). For bTrpRS,
it has been hypothesized that a covalent linkage between
an AMP moiety to an occupant of either the
pyrophosphate- or the Trp-binding subsite is required
for a closed interdomain hinge angle and stabilization of
the closed conformation, which is supported by the recent
3402 Nucleic Acids Research, 2010,Vol.38, No. 10observation that the binding of tryptophan, AMP and
phosphate was unable to convert bTrpRS from an open
conformation of the apo form to a fully closed conforma-
tion (18). In contrast, in both sTrpRS and hTrpRS, the
binding of tryptophan alone leads to a closed overall con-
formation (here and refs 25 and 26), indicating that such a
covalent bond is not necessary for the interdomain
motions in eukaryotic TrpRSs.
In the apo form, sTrpRS forms a symmetric
homodimer with the two monomers related by a 2-fold
crystallographic axis. As shown in Figure 1D,
superposition of the monomers of the sTrpRS–Trp
complex based on the RF domain (residues 100–254 and
264–289) reveals notable structural diﬀerences, consistent
with an RMSD of  1.0A ˚ for about 400Ca atoms.
Compared with the apo enzyme, although the
C-terminal domains of both monomers in the complex
rotate towards the RF domain, the rotation angle of the
C- terminal domain is slightly larger in one monomer
(monomer A, 6.4 ) than in the other (monomer B, 4.7 )
(Supplementary Table S1), resulting in a more compact
conformation of monomer A. Notably, the N-terminal
b-hairpin of monomer B reaches deeper into the catalytic
active site and, correspondingly, the interactions between
the b-hairpin and the KMSAS loop are diﬀerent.
In particular, although Thr293 on the KMSAS loop
forms a hydrogen-bonding interaction with the
main-chain amide of Gly34 on the b-hairpin in both
monomers, the interaction is stronger in monomer B
(3.0A ˚ , via the main-chain carbonyl of Thr293) than in
monomer A (3.4A ˚ , via the side-chain hydroxyl of
Thr293) (Figure 1D). In the sTrpRS–TrpNH2O and
sTrpRS–TrpAMP complexes, the two monomers exhibit
a similar asymmetry (Supplementary Table S1).
Asymmetry between the two monomers has also been
observed in various hTrpRS complexes (20,21,25,26),
indicating that such a phenomenon might be common
for eukaryotic TrpRSs.
Binding of the Trp and AMP moieties
The Trp-binding subsite resides deep in the
substrate-binding pocket. In the sTrpRS complexes, the
bound Trp and TrpNH2O molecules and the tryptophanyl
moiety of TrpAMP occupy almost identical positions
(Supplementary Figure S2) and have similar interactions
with the surrounding residues. Thus, we will use the struc-
ture of the sTrpRS–Trp complex as a representative to
discuss the binding of Trp. To speciﬁcally recognize Trp,
Figure 1. Overall structures of sTrpRS in diﬀerent ligand-bound forms.
(A) Overall structure of sTrpRS in apo form. Two 2-fold
symmetry-related monomers form a dimer. For simplicity, only one
monomer is colored and labeled: the N-terminal domain in magenta,
the RF catalytic domain in cyan, the C-terminal domain in yellow, and
the AIDQ and HLGH motifs in orange and pink, respectively. The
N-terminal 44 residues (including the b-hairpin) and a region
(residues 292–299) containing the conserved KMSAS loop are disor-
dered. (B) Overall structure of sTrpRS in complex with TrpAMP. The
overall structures of sTrpRS in complexes with Trp, TrpNH2O, and
TrpAMP are very similar and the sTrpRS-TrpAMP structure is pre-
sented as a representative. The bound TrpAMP molecules are shown
with ball-and-stick models and colored in light grey. The color codings
of the three domains and the AIDQ and HLGH motifs are the same as
in (A). The N-terminal b-hairpin and the KMSAS motif are deﬁned in
all complexes and are colored in limon and red, respectively. (C)
Superposition of the sTrpRS structures in diﬀerent ligand-bound
forms. The superposition is based on the core region of the RF
catalytic domain (residues 100–254 and 264–289). Several regions
undergo marked conformational changes upon ligand binding, which
are diﬀerentially colored in the sTrpRS structures with the apo form in
yellow and the complexes with Trp in green, with TrpNH2O in magenta
and with TrpAMP in cyan. The bound ligands are shown with
ball-and-stick models and colored accordingly. (D) The asymmetry
between the two monomers of the homodimeric sTrpRS in the
sTrpRS–Trp complex. Conformational diﬀerences of the b-hairpin,
the KMSAS loop and the C-terminal domain between monomer A
(green) and monomer B (purple) of the sTrpRS–Trp complex are
demonstrated. At the active site, the asymmetry of the structure is
accompanied by the diﬀered interactions between the KMSAS loop
and the b-hairpin. The hydrogen bonds between Thr293 and Gly34
are denoted as dashed lines. The monomers of the sTrpRS–TrpNH2O
complex or the sTrpRS–TrpAMP complex are asymmetric in a similar
way, and hence are not shown. (E and F) Stereoviews showing the
interactions between (E) Trp or (F) the AMP moiety of TrpAMP
and the surrounding residues at the active site in the sTrpRS–
TrpAMP complex. The Trp binding modes are very similar in the
sTrpRS–Trp and sTrpRS–TrpNH2O complexes, and hence are not
shown. The involved hydrogen bonds are indicated with dashed lines.
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3404 Nucleic Acids Research, 2010,Vol.38, No. 10sTrpRS forms two hydrogen bonds with the indole
nitrogen of Trp via the phenolic hydroxyl of Tyr106
(2.9A ˚ ) and the carboxyl of Glu141 (3.2A ˚ ) (Figure 1E).
Moreover, the amino group of Trp is stabilized by the
side chains of Glu146 and Gln230 via salt-bridging and
hydrogen-bonding interactions (2.9A ˚ and 3.0A ˚ , respec-
tively), while the carbonyl group of Trp is positioned by
the side-chain amino of Lys147 via a salt bridge. All the
residues that are involved in Trp binding are strictly
conserved in hTrpRS, except Glu141 which is substituted
with Gln194 in hTrpRS (Supplementary Figure S3A),
indicating that the Trp recognition and binding mecha-
nism is highly conserved between the lower and higher
eukaryotes.
Upon Trp binding, sTrpRS undergoes remarkable
conformational changes. With the formation of a
hydrogen bond between Trp and Gln230, the Cd atom
of Gln230 is displaced by 2.4A ˚ and the side chain of
Gln230 rotates to form a new hydrogen bond with the
side-chain carbonyl group of Gln259 of the AIDQ
motif, leading to  3A ˚ movement of the AIDQ motif
towards the active site (Figure 1C and Supplementary
Table S1). The positional displacement of the AIDQ
motif is further coupled with rotations of both the N-
and C-terminal domains towards the RF domain,
leading to the closure of the overall structure (Figure 1C
and Supplementary Table S1). Intriguingly, the
N-terminal b-hairpin and the KMSAS loop of sTrpRS
which are disordered in the apo structure now become
stabilized. Analysis of the interactions between the
b-hairpin and the AIDQ motif shows that with the
movement of the AIDQ motif, helix a15 where
the AIDQ motif resides is also displaced (3–4A ˚ ) and
consequently, residues Pro261 and Tyr262 (with the
re-oriented side chain) of helix a15 make hydrophobic
interactions with Pro29 and Trp30 of the b-hairpin.
Additionally, in the vicinity residue Phe213 on helix a12
reorients its side chain towards the cluster, further
reinforcing the hydrophobic microenvironment.
Meanwhile, the main-chain amide of Gly34 on the
b-hairpin forms a hydrogen bond with residue Thr293
on the KMSAS loop, which may attribute to the stabili-
zation of the ﬂexible loop. These ﬁndings indicate that
upon Trp binding and the AIDQ closure, the b-hairpin
plays a ‘bridging’ role for positioning the KMSAS loop
at a right location for further ATP binding, which
provides the structural basis for the role of the b-hairpin
in ATP binding other than Trp binding as demonstrated
by the previous biochemical data (25).
In the sTrpRS–TrpAMP complex, the adenine moiety
of TrpAMP is covered by the side chain of Phe285, and
the N1 and N6 atoms of the adenine moiety have
hydrogen-bonding interactions with the main-chain
amide and carbonyl of Phe286 (2.8A ˚ and 3.1A ˚ ) and the
main-chain carbonyl of Met296 (3.2A ˚ ), respectively
(Figure 1F). The 20-hydroxyl of the ribose moiety has
two hydrogen-bonding interactions with the main-chain
amide of Ala256 (2.7A ˚ ) and the side-chain carboxyl of
Asp258 (2.6A ˚ ), and the 30-hydroxyl makes an interaction
with the main-chain amide of Ala256 (3.5A ˚ ). The phos-
phate group forms two hydrogen bonds with the
side-chain Ng1 of Arg109 (2.9A ˚ ) and the main-chain
amide of Gly110 (2.7A ˚ ) (Figure 1F). All of the interac-
tions between sTrpRS and the AMP moiety are similar to
those detected in the hTrpRS–TrpAMP complex (26)
(Supplementary Figure S3A), indicating that the AMP
binding mode in the product state is all conserved
among eukaryotic TrpRSs.
Together, the eukaryotic TrpRSs share a similar
TrpAMP binding mode with the archaeal Pyrococcus
horikoshii TrpRS (44), which is diﬀerent from that of the
bacterial bTrpRS (Supplementary Figure S3B). Brieﬂy, in
the bTrpRS–TrpAMP complex, the indole nitrogen of the
tryptophanyl moiety is recognized by Asp132 and Phe5 in
contrast to Glu141 and Tyr106 of sTrpRS. In addition,
the amino and carbonyl groups are bound by Tyr125
and Gln9, respectively, which take the roles of Glu146,
Gln230 and Lys147 of sTrpRS. Most importantly, the
a-phosphate is bound by Lys195 of the KMSKS loop
which is missing in eukaryotic TrpRSs (see ‘Discussion’
section later).
Sulfate binding at the active site
Intriguingly, in the sTrpRS–Trp and sTrpRS–TrpAMP
complexes, there is a sulfate ion bound at the active site
of each monomer, which is most likely introduced during
the crystallization process due to the presence of
ammonium sulfate as a precipitant. Binding of sulfate
ions by TyrRSs has been observed in the structures of E.
coli TyrRS in complexes with tyrosine and TyrAMS, and
the apo A. pernix TyrRS (45,46). In the TyrRS structures
the sulfate ion occupies a position similar to that of the
g-phosphate of ATP and has no interaction with
the KMSKS loop. Structural comparisons of the
sTrpRS–Trp and sTrpRS–TrpAMP complexes and
the hTrpRS–TrpNH2O–ATP complex indicate that the
sulfate ion occupies a position similar to that of the
b-phosphate of ATP (Figure 2A). It imposes hydrogen
bonds with the main-chain amide of Ala298 on the
KMSAS loop and the side chains of His117 and His120
of the HLGH motif, and forms a salt bridge with the
side-chain Ng1 of Arg109 on strand b1 (Figure 2B and
C). As it has been well-documented that the KMSAS
loop of hTrpRS (26) or the KMSKS loop of bTrpRS
(14,16) has a high aﬃnity for the b-phosphate rather
than the g-phosphate, the unique position of the sulfate
ion and its interaction with the KMSAS loop imply that it
mimics the b-phosphate of ATP and correspondingly, the
equivalent phosphate of the leaving pyrophosphate group,
suggesting that the HLGH motif and the KMSAS loop of
sTrpRS are involved in the release of the pyrophosphate
during the nucleophilic reaction.
In the sTrpRS–TrpNH2O complex, there is also a
sulfate ion bound at the active site of each monomer but
in diﬀerent ways compared with that in the sTrpRS–Trp
and sTrpRS–TrpAMP complexes (Figure 2D and E). In
monomer A of the sTrpRS–TrpNH2O complex, the
sulfate ion moves towards TrpNH2Ob y 3A ˚ to form a
hydrogen bond with the amino group of TrpNH2O (2.8A ˚ )
(Figure 2D). Correspondingly, the sulfate ion has no inter-
action with Ala298 of the KMSAS loop or His117 of the
Nucleic Acids Research, 2010,Vol.38, No. 10 3405Figure 2. Sulfate binding in the sTrpRS complexes. (A) Structural comparison of the bound ligands among the sTrpRS complexes and the hTrpRS–
TrpNH2O–ATP complex. There is a sulfate ion bound at each active site of the three sTrpRS complexes. Analyses of the sTrpRS complexes and the
hTrpRS–TrpNH2O–ATP complex show that during the amino activation reaction the Trp moieties remain at similar positions, while the
a-phosphate appears to approach Trp from a distant position observed in the hTrpRS–TrpNH2O–ATP complex (orange) to an intermediate
position similar to that of the sulfate ion in monomer A of the sTrpRS–TrpNH2O complex (magenta), and to a ﬁnal position in the sTrpRS–
TrpAMP complex (cyan) when the reaction is completed. The sulfate ions in the sTrpRS–Trp (green) and sTrpRS–TrpAMP (cyan) complexes
occupy a position equivalent to that of the b-phosphate of ATP in the hTrpRS–TrpNH2O–ATP complex. For clarity, all the ligands are colored in
gray except the a-phosphate of ATP and the sulfate ions. (B–E) Stereoviews showing the interactions of the sulfate ions with the surrounding
residues at the active site in (B) the sTrpRS-Trp complex, (C) the sTrpRS–TrpAMP complex, and (D) monomer A and (E) monomer B of the
sTrpRS–TrpNH2O complex, respectively.
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HLGH motif and Arg109 of strand b1 remain similar.
Consequently, the loss of the interaction between the
sulfate ion and the KMSAS loop leads to a quasi-closed
conformation of the KMSAS loop. In monomer B, the
sulfate ion locates at a position similar to that in
the sTrpRS–Trp and sTrpRS–TrpAMP complexes and
the KMSAS loop assumes a closed conformation
(Figure 2E). Although there are some changes in its inter-
actions with the surrounding residues (Figure 2E), the dif-
ferences seem to be resulted from the rotation of the ion
by a small angle which is not related to the Trp activation
process.
The tryptophan analog TrpNH2O diﬀers from Trp in
that the carboxyl group of tryptophan is replaced by an
amide group, which confers a partial positive charge to
TrpNH2O for potential interaction between TrpNH2O
and the sulfate ion. However, in monomer B of the
sTrpRS–TrpNH2O complex, the position of the sulfate
ion and the conformation of the KMSAS loop remain
the same as in the sTrpRS–Trp complex, indicating that
the change of the electrostatic property of the ligand alone
is not suﬃcient to induce the changes observed in
monomer A. Instead, the substantial diﬀerences in the
sulfate binding mode between monomers A and B can
be attributed to the aforementioned asymmetry of the
monomers: the relatively stronger interactions between
the KMSAS loop and the b-hairpin in monomer B
probably stabilizes the closed conformation of the
KMSAS loop and hence the interactions between the
KMSAS loop and the sulfate ion, whereas in monomer
A with the weaker interactions between the b-hairpin and
the KMSAS loop, the KMSAS loop is not as stable and
hence is unable to restrain the sulfate ion from the attrac-
tion of TrpNH2O. Intriguingly, the sulfate ion observed in
monomer A of the sTrpRS–TrpNH2O complex is located
between the a-phosphate of ATP in the
hTrpRS–TrpNH2O–ATP complex and the phosphate
moiety of TrpAMP in the sTrpRS–TrpAMP complex in
a way that the three ions are basically in line without
overlapping each other (Figure 2A), suggesting that the
sulfate ion might mimic an intermediate state of the
a-phosphate from the pretransition state to the transition
state (see ‘Discussion’ section later).
Molecular dynamics simulation studies of the
hTrpRS complexes
Comparison of the structure of monomer A of the
sTrpRS–TrpNH2O complex with those of the
hTrpRS–TrpNH2O–ATP (representing the pretransition
state) and hTrpRS–TrpAMP/sTrpRS–TrpAMP (repre-
senting the product state) complexes (this study and ref.
26) shows that the positions of Trp and its binding modes
are almost identical during the reaction, whereas the
a-phosphate of TrpAMP shows a positional displacement
of 5.5A ˚ in relation to that of ATP, suggesting that the
a-phosphate of ATP moves towards Trp for the
nucleophilic attack. This now raises questions about
how the a-phosphate group moves and what are the
accompanying events at the active site during the catalytic
process. For bTrpRS, simulation studies of the bTrpRS–
ATP–Mg
2+ and bTrpRS–AQP complexes suggest that
the reaction proceeds through the transition state with
minimum structural and energetic changes and the
coupling of the interactions between Mg
2+ and ATP
and those between ATP and the active-site lysine
residues is necessary to sustain the high-energy state
(16). Moreover, the Mg
2+ functions cooperatively with
the KMSKS loop during the reaction (16). Due to the
unavailability of a structure of eukaryotic TrpRS in
complex with AQP, we built a model of the
hTrpRS–Trp–ATP complex based on the crystal structure
of the hTrpRS–TrpNH2O–ATP complex and carried out
simulations of the model to track the movements of the
substrates and the changes of the surrounding residues
and/or structural elements during the reaction, and to
identify potential interactions that cannot be detected in
the crystal structures. For comparison, the model of the
hTrpRS–ATP complex was built and simulation studies of
this model and the hTrpRS–TrpNH2O–ATP structure
were also performed.
For the hTrpRS–TrpNH2O–ATP complex the theoret-
ical B factors of the protein calculated based on the mean
of squared atomic displacements from the simulation were
compared with the experimental B factors of the crystal
structure. As shown in Figure 3A, the theoretical and
experimental B factors exhibit good correlation in
general except two short regions, providing a good vali-
dation of the MD trajectories. As the simulation was per-
formed with a monomer only, it is not surprising that one
region (approximately residues 260–290) participating in
the dimer formation has higher theoretical B factors. The
other region (approximately residues 390–400) is involved
in crystal packing, which may account for its lower B
factors in the crystal structure. Consistent with the obser-
vation that the positions of the Trp moieties are almost
identical in the pretransition state and the product state
(26), during the 5ns simulations Trp or TrpNH2O is gen-
erally stable showing very small deviations. Therefore, the
oxygen bridging the Trp moiety and the AMP group is
assumed to occupy a position close to that of the
nucleophilic oxygen at the transition state. For clarity,
the hTrpRS–TrpAMP complex (26) was superposed to
the hTrpRS–TrpNH2O–ATP structure and the bridging
oxygen atom between the Trp and AMP moieties served
as a reference for the positions of the moving a-phosphate
of ATP during all the simulations. For the hTrpRS–
Trp–ATP complex which represents the pre-transition
state, the simulation results show that the conﬁgurations
of the residues at the active site remain similar except
for residue Arg162 (see ‘Discussion’ section later). In
addition, the presence or absence of Mg
2+ does not
appear to have any signiﬁcant eﬀect. However, as Mg
2+
was docked to the complex based on the bTrpRS–ATP–
Mg
2+ structure (13), the contribution of Mg
2+ in the Trp
activation mechanism of eukaryotic TrpRSs needs further
assessment. As shown in Figure 3B, in the presence of
tryptophan, the Pa atom of ATP moves quickly towards
tryptophan during the beginning 200ps, then oscillates
while continuing to approach tryptophan (200–800ps),
followed by stable behavior with modest ﬂuctuations
Nucleic Acids Research, 2010,Vol.38, No. 10 3407at positions of  2A ˚ from the reference atom (>800ps).
As the bridging oxygen in TrpAMP is assumed to take a
position close to that of the attacking nucleophile during
the reaction, the results suggest that the distance between
the nucleophile of tryptophan and the Pa atom of ATP
may be as short as 2A ˚ , which is close to the distance of
 1.7A ˚ proposed for an associative mechanism (17). Such
changes only occur when both tryptophan and ATP are
present, as in the simulations of the hTrpRS–TrpNH2O–
ATP and hTrpRS–ATP complexes, the respective dis-
tances between Pa of ATP and the reference position
remain at 6–7A ˚ (Figure 3B), implying that the binding
of tryptophan and ATP at the right positions and the
subsequent attraction between the carboxylate of
tryptophan and the positively charged Pa of ATP initiate
the reaction.
Intriguingly, the sulfate ion in monomer A of the
sTrpRS-TrpNH2O complex occupies a position similar
to that of the a-phosphate of ATP during 200–600ps of
the simulation of the hTrpRS–Trp–ATP complex (with a
comparison of the structure with the scheme of the simu-
lation at 450 ps being presented in Figure 3C), implying
that the sulfate ion may mimic an intermediate state of the
a-phosphate prior to phosphoryl transfer and thus
Figure 3. Molecular dynamics simulations of the hTrpRS complexes. (A) Comparison of the theoretical B factors of the Ca atoms of the TrpRS–
TrpNH2O–ATP complex during the MD trajectories (black) with the crystallographic B factors (red). The calculated B factors correlate well with the
experimental B factors in general. (B) Displacement of Pa of ATP during the simulation of the hTrpRS–Trp–ATP complex. The hTrpRS–TrpAMP
complex was superposed with the hTrpRS–TrpNH2O–ATP complex, and the oxygen atom bridging the AMP and Trp moieties of TrpAMP (which
adopts a position approximating that of the nucleophilic oxygen at the transition state) served as a reference to the moving a-phosphate of ATP for
the simulation studies. During the beginning 1.5ns of the 5ns simulations of the hTrpRS–Trp–ATP (red), hTrpRS–TrpNH2O–ATP (black) and
hTrpRS–ATP (green) complexes, the respective distances between Pa of ATP and the reference position were measured and compared. (C)
Comparison of the conformations of ATP, Trp and Arg162
H at 450ps of the simulation of the hTrpRS-Trp-ATP complex (orange) with those
of the sulfate ion, TrpNH2O and Arg109
S in monomer A of the sTrpRS-TrpNH2O complex (magenta). The superposed hTrpRS–TrpAMP complex
(cyan) is also included as a positional reference. For clarity, the ligands are colored in gray except the a-phosphate groups and the sulfate ion.
Residues Arg162
S and Arg109
H are labeled and colored accordingly. (D) Potential interaction of Arg162
H with the oxygen bridging the a-phosphate
and the b,g-pyrophosphate group of ATP at the transition state. During the simulation of the hTrpRS–Trp–ATP complex, an interaction between
Arg162 and the bridging oxygen (indicated by a dashed line) is formed when the Pa atom is about 2A ˚ from the nucleophile. A representative scheme
at 860ps of the simulation is shown. The color codings are the same as above.
3408 Nucleic Acids Research, 2010,Vol.38, No. 10represent a snapshot of the a-phosphate motion during
the tryptophan activation reaction. Albeit in monomer
A of the sTrpRS–TrpNH2O complex a salt bridge is
formed between Arg109 (equivalent to Arg162 of
hTrpRS) and the sulfate ion, Arg162 cannot make a
salt-bridging or hydrogen-bonding interaction with the
a-phosphate group during this period. Further progres-
sion of the simulation (>800 ps) shows that in states
approximating an associative transition state with Pa of
ATP at positions of about 2A ˚ from the reference oxygen,
Arg162 interacts with the oxygen bridging the
a-phosphate and the b,g-pyrophosphate group
(Figure 3D), suggesting an important role of Arg162 for
the bond cleavage and the stabilization of the leaving
group (see ‘Discussion’ later).
DISCUSSION
Mechanism of tryptophan activation by eukaryotic
TrpRSs
With multiple bTrpRS structures and the related simula-
tion studies, Retailleau et al. proposed that bTrpRS uses a
dissociative mechanism in the tryptophan activation
reaction (16–18). In particular, in the bTrpRS–AQP struc-
ture, the a-phosphate of AQP shows a positional displace-
ment of 0.4A ˚ towards the tryptophan carboxylate
nucleophile compared with the a-phosphate of ATP in
the closed bTrpRS–ATP–Mg
2+ complex, and the g- and
d-phosphates mimic the pyrophosphate leaving group
(17). The distance between Pa and the oxygen atom
bridging the b- and g- phosphates is 2.7A ˚ , which is close
to the expected 3.3A ˚ of a dissociative transition state,
hence favoring a catalytic mechanism with dissociative
character for bTrpRS (17). Due to the limited structural
information of eukaryotic TrpRSs, the molecular mecha-
nism of nucleophilic substitution in the tryptophan acti-
vation remains unclear. Analysis of the crystal structures
of the sTrpRS complexes and the simulation studies of the
hTrpRS complexes presented here shed some light onto
the mechanism of Trp activation by eukaryotic TrpRSs.




B) have been shown to
play important roles in the transition state (16–19) (for
simplicity, hereafter the residues of bTprRS, sTrpRS
and hTrpRS are denoted with superscripted letters B, S
and H, respectively). Speciﬁcally, in the transition-state
model constructed based on the bTrpRS-AQP structure,
Lys195
B contributes to charge stabilization of the oxygen
atom in the scissile bond, suggesting a critical role of the
residue in the nucleophilic attack (17). Consistently,
mutation of the residue to Ala resulted in about 100-fold
decrease in kcat (19). In eukaryotic TrpRSs, there is no
residue equivalent to Lys111
B (as Lys111
B is located in
an insertion of bTrpRS compared with eukaryotic
TrpRSs) and the residue equivalent to Lys195
B is an Ala
residue (Ala298
S or Ala352
H) which is unable to interact
with the oxygen atom. Instead, a sequentially distant Arg
(Arg109
S or Arg162
H) seems to take a similar role as
Lys195
B. In the hTrpRS–TrpNH2O–ATP complex,
Arg162
H interacts solely with the g-phosphate. However,
in the hTrpRS–TrpAMP complex the a-phosphate group
has a positional displacement of 5.5A ˚ towards the Trp
moiety, and correspondingly the side chain of Arg162
H
reaches a position similar to Lys195
B from an opposite
direction and forms a salt bridge with the phosphate of
TrpAMP which is equivalent to the a-phosphate of ATP
(26). In the sTrpRS–TrpAMP structure, Arg109
S binds to
the phosphate of TrpAMP (Figure 1F) and additionally to
the sulfate ion which mimics the b-phosphate of the
leaving group (Figure 2D), suggesting that Arg109
S
plays a role in stabilization of the newly formed
product. Consistently, the computational studies show
that during the simulations of the hTrpRS–Trp–ATP
complex, Arg162
H interacts with the oxygen bridging Pa
and Pb of ATP, implying that Arg162
H might facilitate to
stabilize the increased negative charge on this atom during
phosphoryl transfer (Figure 3D). Together, these ﬁndings
imply that in eukaryotic TrpRSs, the Arg residue probably
compensates for the missing Lys of the KMSKS motif by
facilitating the cleavage of the bond between the a- and
b-phosphates of ATP and the stabilization of both Pa and
the pyrophosphate leaving group.
The proposed critical functions of this Arg residue and
the requirement of displacement of the a-phosphate of
ATP in the catalytic process well explain the biochemical
data (25). Previously, the mutational study showed that
Arg162
H (equivalent to Arg109
S) plays a critical role in
ATP binding and/or the catalysis as the R162A mutant of
hTrpRS had substantially decreased ATP aﬃnity and
catalytic activity (25). When Ala352
H (equivalent to
Ala298
S) was further mutated to generate the R162A/
A352K double mutant, the ATP binding aﬃnity was
restored, however, the catalytic activity was not rescued,
providing further evidence for an indispensible role of
Arg162
H in the catalysis. Moreover, the R162A/A352K
double mutant appeared to have an even lower catalytic
activity than R162A with a decreased kcat (0.01 versus
0.05s
 1) (25). Considering that the KMSKS loop where
Ala352 resides interacts with the a- and b-phosphate
groups in the pre-transition state (26), conversion of
Ala352 to Lys might enhance the interactions between
the KMSAS loop and the triphosphate group of ATP,
and consequently impede the movement of the
a-phosphate towards tryptophan during the catalytic
process.
Although Arg162
H functions in the bond cleavage and
the product stabilization, it does not act exactly the same
as Lys195
B. For bTrpRS, in the modeled transition state,
the distance between the Trp carboxylate and Pa is about
 3.5A ˚ , which is very close to the expected distance of
3.3A ˚ for a dissociative transition state, and Lys195
B is
considered to interact with the oxygen bridging Pa and
Pb of ATP to compensate for the increased negative
charge on this oxygen during the reaction (17). In the
pre-transition state of hTrpRS (26), Arg162
H locates at
the opposite side of the phosphate group relative to
Lys195
B and is unlikely to reach the bridging oxygen
between a- and b-phosphates with the distance of 5.3A ˚
(26). During the simulation of the hTrpRS–Trp–ATP
complex, the possibility of formation of a hydrogen
bond between Arg162
H and the bridging oxygen was
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tryptophan carboxylate. Our analysis shows that under
this circumstance the distance between Arg162
H and the
bridging oxygen is larger than 4.5A ˚ , implying that such an
interaction is unlikely to form as in bTrpRS. As the inter-
actions of Lys195
B of the KMSKS loop and Asn18
B of the
TIGN motif (equivalent to the HVGH motif of hTrpRS)
with this oxygen atom in the scissile bond are important to
compensate the increased negative charge on the atom in
the proposed dissociative mechanism for bTrpRS (17), the
incapability of Arg162
H to execute a similar function as
Lys195
B under an equivalent situation and the replace-
ment of Asn18
B by a weakly charged residue His173
H
would substantially reduce the eﬀect and hence our
results do not favor a dissociative mechanism. On the
other hand, considering that at the transition state Pa of
Figure 4. Conformational diﬀerences of the Trp-binding subsite between the apo sTrpRS and hTrpRS structures. (A) Electrostatic surfaces of the
Trp-binding pockets in the apo sTrpRS (left panel) and hTrpRS (right panel) structures. A tryptophan molecule is docked to show the Trp-binding
subsite. (B) Structural comparison of the Trp-binding subsite of the apo sTrpRS (yellow) with that of the apo hTrpRS (cyan). The residues
responsible for the structural diﬀerences are labeled and shown with stick-and-ball models. The sequence variance at position Val265
S/Met319
H
is a key for the structural diﬀerences of the Trp-binding subsite. (C) Sequence alignment of sTrpRS with TrpRSs from other yeasts including
C. glabrata, C. albicans and S. pombe, and with those from higher eukaryotes including H. sapiens and B. taurus. The position equivalent to that of
Val265
S/Met319
H is marked by an asterisk. The sequence alignment is generated by ESPript (58).
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oxygen (Figure 3B) and simultaneously an interaction
forms between Arg162
H and the oxygen bridging Pa and
Pb of ATP (Figure 3D), our data suggest an associative
mechanism of Trp activation by eukaryotic TrpRSs,
which is in accordance with the conclusion of the
previous investigation of the phosphoryl transfer
reaction of bovine TrpRS by examination of the primary
and secondary oxygen kinetic isotope eﬀects (47).
Implications for anti-fungal drug design
Due to their essential roles in protein synthesis, aaRSs
have been therapeutic targets against microbial infections.
To date, mupirocin (Bactroban
TM), a potent inhibitor of
bacterial IleRS, has been clinically applied to treat skin
infections caused by Gram-positive bacteria (48,49). For
fungal infections, an LeuRS inhibitor (AN-2690) and an
IleRS inhibitor (icofungipen) have been shown to be eﬀec-
tive and are currently evaluated under clinical trials
(50–53). For suppression of TrpRSs, two antibiotics,
namely indolmycin (54,55) and chuangxinmycin (56)
which are the biosynthetic derivatives of L-tryptophan,
have been developed to treat bacterial infections.
However, no inhibitor speciﬁc for fungal TrpRSs is avail-
able, probably due to the high sequence similarities
(>40%) among eukaryotic TrpRSs.
Structural information has been successfully employed
in drug design and development by discovering meticulous
diﬀerences between homologous proteins and revealing
the details of interactions between drugs and their target
proteins. Recently, crystal structures of human and fungal
cytosolic LeuRS editing domains were determined, pro-
viding hints for optimization of available drugs such as
AN-2690 and rational design of new drugs to improve the
potency or enhance the speciﬁcity towards particular
pathogens (57). Similarly, a detailed comparison between
the apo form structures of sTrpRS and hTrpRS (this study
and ref. 26) shows that although their overall structures
and the structures of the active site are quite similar, local
diﬀerences exist in the Trp-binding subsite. In particular,
compared with hTrpRS, sTrpRS has an additional small
cavity at the Trp-binding subsite (Figure 4A). Such a
feature is also observed in the previously reported struc-
ture of the apo sTrpRS grown from a diﬀerent crystalli-
zation condition (43), indicating that the observed
diﬀerences are caused by intrinsic characters.
Analysis of the residues comprising the Trp-binding
subsite reveals conformational diﬀerences of the residues





H, respectively). In sTrpRS, the aromatic
ring of Tyr262
S points towards the active site interacting
with Gln230
S via a hydrogen bond, whereas in hTrpRS,
the side chain of Tyr316
H ﬂips toward outside without a
detectable interaction with Gln284
H, leaving the side chain
of Gln284
H in a distinct orientation (Figure 4B). Analysis
of the residues in the vicinity shows that in hTrpRS, a
neighboring residue Phe267
H takes a conformation diﬀer-
ent from that of the equivalent Phe213
S, which does not
allow Tyr316
H to take a conformation similar to that of
Tyr262
S. Further analysis shows that the conformational
diﬀerence between Phe267
H and Phe213
S is resulted from
a sequence diﬀerence at a position corresponding to
Met319
H or Val265
S. In the superposed structures,
Met319
H occupies a similar position as Val265
S;
however, with a signiﬁcantly larger side chain, the
distance between Met319
H and Phe213
S is about 1.8A ˚ ,
indicating a potential steric conﬂict. Thus, the side chain
of Phe267
H takes a conformation diﬀerent from that of
Phe213






S appear to play a fundamental role
for the observed conformational diﬀerences of the
Trp-binding subsites between sTrpRS and hTrpRS.
Inspiringly, sequence alignment indicates that the Val
residue (equivalent to Val265
S) is conserved among
many yeast genera including Candida, while Met is
conserved among higher eukaryotes (Figure 4C). Thus,
compounds with selectivity for the Trp-binding subsite
of the apo fungal enzymes over that of the mammalian
enzymes and further with ability to lock the fungal
TrpRSs in an open conformation would be beneﬁcial for
speciﬁc suppression of fungal TrpRSs in mammalians.
Therefore, our ﬁndings open a possibility to discriminate
between TrpRSs from the pathogenic fungal genera and
the mammalian TrpRSs, and hence will allow de novo
rationalized drug design targeting fungal TrpRSs.
PROTEIN DATA BANK ACCESSION CODES
The structures of S. cerevisiae TrpRS in apo form and in
complexes with Trp, TrpNH2O and TrpAMP have been
deposited with the RCSB Protein Data Bank under acces-
sion codes 3KT0, 3KT6, 3KT8 and 3KT3, respectively.
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